Literature DB >> 2342811

Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment.

G Soubrane1, G Coscas, C Français, F Koenig.   

Abstract

Little information is available on the natural history and no data have been published on laser treatment for occult neovascularization in age-related macular degeneration. The visual and angiographic outcomes were analyzed in 156 patients (82 untreated eyes; 81 treated eyes) with occult neovascularization who were followed for 1 to 8 years. Early laser treatment decreased visual acuity to less than 20/200 in 31 of the treated eyes (38%) compared with 20 of the untreated eyes (25%). Three years after the onset of symptoms, 24 treated eyes (29%) and 31 eyes untreated eyes (38%) retained 20/50 visual acuity or better, whereas their respective initial visual acuities were not statistically different. Severe loss of vision (6 or more lines of visual acuity) occurred in 43 treated eyes (53%) and in 33 untreated eyes (40%) at the end of follow-up (range, 12-84 months). A slow and gradual increase of the disciform lesion was demonstrated on fluorescein angiography in 60 untreated eyes, with subfoveal involvement noted in 39 eyes at the end of follow-up. In the treated group, subfoveal involvement occurred in 53 eyes, after a relatively short time (mean, 4 months). Only 28 of the 81 treated eyes had successful anatomic results. These findings suggested that laser treatment of occult neovascularization immediately after the onset of symptoms should not be recommended.

Entities:  

Mesh:

Year:  1990        PMID: 2342811     DOI: 10.1016/s0161-6420(90)32530-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  21 in total

1.  A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  C Valmaggia; G Ries; P Ballinari
Journal:  Doc Ophthalmol       Date:  2001-11       Impact factor: 2.379

2.  Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study.

Authors:  G Donati; D Soubrane; M Quaranta; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

3.  Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration.

Authors:  A Weber; A E Elsner; M Miura; S Kompa; M C Cheney
Journal:  Eye (Lond)       Date:  2006-01-06       Impact factor: 3.775

4.  Grid laser treatment of occult choroidal neovascularization in age related macular degeneration.

Authors:  F Cardillo Piccolino; D Ghiglione; P Allegri
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

5.  Low dose radiation for subfoveal choroidal neovascularization in age-related macular degeneration. A pilot study: radiotherapy for age-related macular degeneration.

Authors:  C Valmaggia; P Bischoff; G Ries; W Seelentag; H Niederberger; P Speiser
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

6.  Low-dose radiation therapy for age-related macular degeneration.

Authors:  H Pöstgens; S Bodanowitz; P Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

7.  A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration.

Authors:  S Da Pozzo; M B Parodi; G Ravalico
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

8.  The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.

Authors:  A Ozkaya; C Alagoz; R Garip; Z Alkin; I Perente; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-04-15       Impact factor: 3.775

9.  Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation.

Authors:  A W Weinberger; H Knabben; U Solbach; S Wolf
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

10.  [Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up].

Authors:  M Feucht; B Fuisting; G Richard
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.